All Business articles – Page 8
View all stories with this category.
-
OpinionWould you buy synthetic wine?
Can we replicate the chemical profiles of famously expensive drinks? And would people drink them?
-
Business
Power-hungry Tesla picks up supercapacitor maker
Maxwell Technologies deal highlights potential for supercapacitors in electric vehicles and beyond
-
Business
Smartwound dressings spot infection early
Bacterial toxins burst dye-filled vesicles to give a visual warning
-
Opinion
We’re going to need a bigger flask
Scaling up reactions is easy to get wrong in a variety of ways
-
Opinion
Divergent reality
If the UK leaves the EU without a deal, the two will inevitably drift further apart
-
Business
What might Brexit mean for industry?
Questions hang over regulation, trade, talent and investment
-
-
Business
US government sued for delaying dichloromethane paint stripper ban
Environmental Protection Agency advances long-awaited ban on consumer products, but allows commercial use to continue
-
Opinion
In search of ultimate selectivity
A catalyst that reacts only with aryl iodides, spurning bromides and chlorides
-
News
Big costs, no benefits to UK’s replacement for EU chemical regulation
Industry warns small volume chemicals could no longer be sold in the UK
-
Business
UK government sets out antimicrobial resistance plan
Aims to cut antibiotic use and explore financial incentives for pharmaceutical companies
-
Opinion
Thinking differently about waste
Plastic and carbon emissions are valuable resources we can’t afford to discard
-
Business
Battling the US opioid epidemic
Adapt pharma’s naloxone nasal spray makes treating overdoses easier
-
Sponsored
Pittcon 2019: the visible difference in laboratory science expositions
The Pennsylvania Convention Center in Philadelphia, Pennsylvania welcomes the 70th annual Pittcon.
-
Business
Antifouling coatings cling to copper
Copper coatings keep ships clear from unwanted sea life but environmental concerns mean some are keen to move away from the metal. Can it be replaced?
-
Opinion
What are the rate-limiting steps in drug discovery?
Getting more drugs to market is not just a chemistry problem
-
Business
Pfizer to close two manufacturing plants in India
Closures will lead to the loss of 1700 jobs – almost 6% of the pharma giant’s manufacturing workforce
-
Business
Chinese plant closures disrupt supply chains
Environmental clampdown knocks out major suppliers of some ingredients
-
Business
Bristol-Myers Squibb to buy Celgene for $74 billion
Deal boosts BMS’s cancer and immunology pipeline with 5 drugs in late stage clinical trials
-
News
First building-integrated deployment shows perovskite solar’s growing maturity
Modules based on lightweight printed hybrid organic-inorganic films start to collect important real-world data
